Approval for a tapered version of the interfix(tm) threaded fusion device. the device, as modified, will be marketed under the trade name lt-cage(tm) tapered fusion device and is indicated for spinal fusion procedures in skeletally mature patients with degenerative disc disease (ddd) at one level from l2-s1.  Ddd is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies.  These ddd patients may also have up to grade i spondylolisthesis or retrolisthesis at the involved level.  Lt-cage(tm) implants are to be used with autogenous bone graft and implanted via a laparoscopic or an open anterior approach.  Patients receiving the lt-cage(tm) lumbar tapered fusion device should have had at least six months of nonoperative treatment prior to treatment with the lt-cage(tm)